共 25 条
[1]
Au WY(2011)Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study Blood 118 6535-43
[2]
Kumana CR(2012)Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation Blood 119 5133-5143
[3]
Lee HK(2002)Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol Leukemia 16 2185-2189
[4]
Man CH(2005)Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia Blood 106 3768-3776
[5]
Fung TK(2010)Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review Leuk Res 34 831-836
[6]
Ho C(2011)Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA Haematologica 96 1799-807
[7]
Noguera NI(2006)Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy Leukemia 20 35-41
[8]
Breccia M(undefined)undefined undefined undefined undefined-undefined
[9]
Divona M(undefined)undefined undefined undefined undefined-undefined
[10]
Gale RE(undefined)undefined undefined undefined undefined-undefined